The price of Yield10 Bioscience Inc (NASDAQ: YTEN) closed at $0.38 in the last session, down -2.38% from day before closing price of $0.39. In other words, the price has decreased by -$0.0107 from its previous closing price. On the day, 1658351 shares were traded.
Ratios:
We take a closer look at YTEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
On September 10, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
National Securities Upgraded its Neutral to Buy on August 27, 2020, while the target price for the stock was maintained at $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’23 when SCHULER JACK W sold 36,000 shares for $0.21 per share. The transaction valued at 7,430 led to the insider holds 1,566,956 shares of the business.
SCHULER JACK W sold 35,000 shares of YTEN for $8,320 on Dec 08 ’23. The 10% Owner now owns 1,602,956 shares after completing the transaction at $0.24 per share. On Oct 06 ’23, another insider, SCHULER JACK W, who serves as the 10% Owner of the company, sold 37,931 shares for $0.30 each. As a result, the insider received 11,448 and left with 872,956 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, YTEN now has a Market Capitalization of 5.84M and an Enterprise Value of 7.98M. For the stock, the TTM Price-to-Sale (P/S) ratio is 96.99. Its current Enterprise Value per Revenue stands at 133.03 whereas that against EBITDA is -0.57.
Stock Price History:
Over the past 52 weeks, YTEN has reached a high of $3.29, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is 0.2848, while the 200-Day Moving Average is calculated to be 0.5792.
Shares Statistics:
According to the various share statistics, YTEN traded on average about 5.01M shares per day over the past 3-months and 4.11M shares per day over the past 10 days. A total of 15.40M shares are outstanding, with a floating share count of 12.41M. Insiders hold about 19.42% of the company’s shares, while institutions hold 3.94% stake in the company. Shares short for YTEN as of Mar 15, 2024 were 239.91k with a Short Ratio of 0.05, compared to 346.58k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.00% and a Short% of Float of 2.19%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.13, while EPS last year was -$0.76. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.15 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.62 and -$0.89 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.85, with 1 analysts recommending between -$0.85 and -$0.85.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $1.87M. It ranges from a high estimate of $2.25M to a low estimate of $1.5M. As of the current estimate, Yield10 Bioscience Inc’s year-ago sales were $60k, an estimated increase of 3,016.70% from the year-ago figure.
A total of 2 analysts have provided revenue estimates for YTEN’s current fiscal year. The highest revenue estimate was $3M, while the lowest revenue estimate was $1.5M, resulting in an average revenue estimate of $2.25M. In the same quarter a year ago, actual revenue was $60k, up 3,650.00% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $4M in the next fiscal year. The high estimate is $4M and the low estimate is $4M. The average revenue growth estimate for next year is up 77.80% from the average revenue estimate for this year.
